Takeda Pharmaceutical Company Limited Unused Tax Credits For Which No Deferred Tax Asset Recognised
Takeda Pharmaceutical Company Limited (TKPHF) had Unused Tax Credits For Which No Deferred Tax Asset Recognised of JPY 26.99 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Income Taxes
ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised · last filed 2025-06-25
- 2025-03-31: Unused Tax Credits For Which No Deferred Tax Asset Recognised 26.99B JPY.
- 2024-03-31: Unused Tax Credits For Which No Deferred Tax Asset Recognised 23.72B JPY.
- 2023-03-31: Unused Tax Credits For Which No Deferred Tax Asset Recognised 11.19B JPY.
- 2022-03-31: Unused Tax Credits For Which No Deferred Tax Asset Recognised 10.04B JPY.
| Period end | Unused Tax Credits For Which No Deferred Tax Asset Recognised |
|---|---|
| 2025-03-31 | 26.99B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 23.72B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 11.19B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 10.04B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 9.66B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 9.28B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 6.05B JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 7.95B JPY 20-F · filed 2019-06-27 |